Stockreport

Co-Diagnostics down 39% on proliferation of COVID-19 competitors [Seeking Alpha]

Co-Diagnostics, Inc.  (CODX) 
US:NASDAQ Investor Relations: ir.codiagnostics.com/investor-relations
PDF Co-Diagnostics ( CODX -38.9% 72% Today's action represents profit-taking and the (now) widespread availability of testing services for patients. Adding to the selloff wa [Read more]